Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

BZ

Kanzhun (BZ)

Kanzhun Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BZ
DatumZeitQuelleÜberschriftSymbolFirma
27/12/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
17/12/202412h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BZKanzhun Ltd
17/12/202412h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BZKanzhun Ltd
16/12/202422h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
11/12/202412h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
11/12/202411h55GlobeNewswire Inc.KANZHUN LIMITED Announces Third Quarter 2024 Financial ResultsNASDAQ:BZKanzhun Ltd
09/12/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
06/12/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
05/12/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
04/12/202412h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
03/12/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
02/12/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
29/11/202412h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
29/11/202409h30GlobeNewswire Inc.KANZHUN LIMITED to Report Third Quarter 2024 Results on December 11, 2024NASDAQ:BZKanzhun Ltd
28/11/202417h00GlobeNewswire Inc.KANZHUN LIMITED Continues Share Repurchase Program, Buying Back RMB1.4 Billion Worth of Ordinary SharesNASDAQ:BZKanzhun Ltd
28/11/202414h06PR Newswire (US)Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC PipelineNASDAQ:BZKanzhun Ltd
27/11/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
26/11/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
22/11/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
21/11/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
20/11/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
19/11/202412h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
18/11/202412h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
15/11/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
14/11/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
13/11/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
07/11/202412h14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
06/11/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
05/11/202412h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
04/11/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BZKanzhun Ltd
 Showing the most relevant articles for your search:NASDAQ:BZ